American Oncology Institute (AOI) has launched of one of the largest Bone Marrow Transplant (BMT) programmes in India, further solidifying its commitment to providing world-class healthcare services. The programme has expanded to cities like Nagpur, Vijayawada, Hyderabad, and Imphal, aiming to meet the growing demand for specialised BMT services.  

Blood cancers constitute 8.2% of all cancers, and in India, its incidence is 5.5 cases per 1 lakh population per year. About 80,000 new blood cancer cases are detected per year, and one new blood cancer is reported every 7 seconds in India. The need for Bone Marrow Transplant programmes in India has never been more critical.

BMT is a life-saving procedure for various life-threatening conditions, including cancers like leukemia, lymphoma, multiple myeloma and benign condition like thalassemia and aplastic anaemia. The shortage of advanced BMT facilities in the country has been a pressing issue, and AOI's expansion addresses this gap by offering state-of-the-art cost effective BMT services to a larger population.  

Dr Amit Dhawan, Regional Chief Operating Officer (RCOO), AOI, said, "With the expansion of our BMT programme, we are taking another step towards achieving that goal, ensuring that patients in states across India have access to advanced medical treatments." 

With the expansion of its BMT programme, American Oncology Institute (AOI) is poised to make a substantial difference in the lives of patients across multiple states in India.